Deadly Brain Tumors Show Vulnerability to New Sound Wave Approach
UVA Health researchers have found that gliomas, the most common primary brain tumors in adults, may be more receptive to focused ultrasound drug delivery than normal brain tissue.
Q&A: What is the memory erasing condition Katie Couric experienced?
A UVA neurologist explains what global transient amnesia is, and what remains a mystery.
Interest in Neuroscience Leads UVA Researcher to Alzheimer’s Insights That Could Improve Treatment
Kareem El-Ghazawi, a graduating Ph.D. student in the UVA Department of Biomedical Engineering, found evidence that pericytes play a larger role in Alzheimer’s disease than previously recognized. His findings will be published in Nature’s Communications Biology.
UVA researchers find brain signal linked to communication challenges in autism
The study identifies a biological clue that could one day help track therapies and improve care.
Postoperative Delirium May Leave an Epigenetic “Memory” in the Brain
Researchers at the University of Virginia School of Medicine have uncovered evidence that postoperative delirium, a sudden loss of cognition that develops after surgery, may leave a molecular imprint on the aging brain, helping explain why the condition is associated with poorer long-term cognitive outcomes in older adults.
Multidisciplinary Clinic Faculty Spotlight: Alissa Higinbotham, MD, Streamlines Care for Patients With Normal Pressure Hydrocephalus
At the clinic, Dr. Higinbotham works closely with Michael Catalino, MD, assistant professor in the Department of Neurosurgery, and Aubrey Courville, DPT, clinical specialist in neurologic physical therapy, to “streamline the evaluation process and reduce the diagnostic odyssey” associated with iNPH, a neurological disorder that occurs when fluid builds up in the brain, stretching neuronal networks.
WHERE DISCOVERY HAPPENS
GET THE STORIES BEHIND THE RESEARCH
Receive updates about the discoveries, researchers, and ideas shaping our world — straight from UVA.
Shooting for the Stars: UVA Lab’s New Gene Therapy May End Pediatric Seizures
When University of Virginia graduate student Caeley Reever came across the word “stellular” – “little star” in Latin – she and UVA anesthesiology professor Manoj Patel knew they had the perfect name for their startup company.
Stellula Therapeutics is centered around developing a gene therapy for a rare pediatric genetic epilepsy disorder, SCN8A developmental and epileptic encephalopathy.
Discovery Shows How Cancer Takes Hold As Cells Divide
Noelle D. Dwyer and team have revealed how mistakes in the final step of cell division can have dire consequences for developing brain cells.
Biology Professor Sarah Kucenas Appointed Associate Dean for Research
In this new role, Kucenas will strategically lead research initiatives for her school. She will help shape its vision by mentoring faculty, promoting…
HOOS in STEM with Lori McMahon
PodcastThis episode of Hoos in Stem features Lori McMahon, UVA’s new Vice President for Research. Lori arrived on Grounds in June, armed with an impressive…